BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31171518)

  • 1. Antiplatelet Therapy in Patients with Aneurysmal SAH: Impact on Delayed Cerebral Ischemia and Clinical Outcome. A Meta-Analysis.
    Cagnazzo F; Derraz I; Lefevre PH; Gascou G; Dargazanli C; Riquelme C; Perrini P; di Carlo D; Bonafe A; Costalat V
    AJNR Am J Neuroradiol; 2019 Jul; 40(7):1201-1206. PubMed ID: 31171518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-treatment Antiplatelet Therapy Reduces Risk for Delayed Cerebral Ischemia due to Aneurysmal Subarachnoid Hemorrhage.
    Darkwah Oppong M; Gembruch O; Pierscianek D; Köhrmann M; Kleinschnitz C; Deuschl C; Mönninghoff C; Kaier K; Forsting M; Sure U; Jabbarli R
    Neurosurgery; 2019 Dec; 85(6):827-833. PubMed ID: 30544176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiplatelet therapy in aneurysmal subarachnoid hemorrhage: a systematic review.
    Dorhout Mees SM; Rinkel GJ; Hop JW; Algra A; van Gijn J
    Stroke; 2003 Sep; 34(9):2285-9. PubMed ID: 12881605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiplatelet therapy and outcomes after aneurysmal subarachnoid hemorrhage: A systematic review and meta-analysis.
    Garton ALA; Berger K; Merkler AE; Kamel H; Knopman J; Zhang C; Murthy SB
    Clin Neurol Neurosurg; 2023 Dec; 235():108025. PubMed ID: 37925994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiplatelet therapy for aneurysmal subarachnoid haemorrhage.
    Dorhout Mees SM; van den Bergh WM; Algra A; Rinkel GJ
    Cochrane Database Syst Rev; 2007 Oct; 2007(4):CD006184. PubMed ID: 17943892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual antiplatelet therapy does not improve outcomes after aneurysmal subarachnoid hemorrhage compared with aspirin monotherapy.
    Wallace AN; Kayan Y; Almandoz JED; Mulder M; Milner AA; Scholz JM; Stiernagle K; Contestabile E; Tipps ME
    Clin Neurol Neurosurg; 2020 Aug; 195():106038. PubMed ID: 32650208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of aspirin and anticoagulant usage on outcomes after aneurysmal subarachnoid hemorrhage: a Nationwide Inpatient Sample analysis.
    Dasenbrock HH; Yan SC; Gross BA; Guttieres D; Gormley WB; Frerichs KU; Ali Aziz-Sultan M; Du R
    J Neurosurg; 2017 Feb; 126(2):537-547. PubMed ID: 27058205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual antiplatelet therapy in aneurysmal subarachnoid hemorrhage: association with reduced risk of clinical vasospasm and delayed cerebral ischemia.
    Nagahama Y; Allan L; Nakagawa D; Zanaty M; Starke RM; Chalouhi N; Jabbour P; Brown RD; Derdeyn CP; Leira EC; Broderick J; Chimowitz M; Torner JC; Hasan D
    J Neurosurg; 2018 Sep; 129(3):702-710. PubMed ID: 29099296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of statin treatment on vasospasm-related morbidity and functional outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis.
    Shen J; Huang KY; Zhu Y; Pan JW; Jiang H; Weng YX; Zhan RY
    J Neurosurg; 2017 Aug; 127(2):291-301. PubMed ID: 27715439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of Cilostazol in Prevention of Delayed Cerebral Ischemia after Aneurysmal Subarachnoid Hemorrhage: A Meta-Analysis.
    Saber H; Desai A; Palla M; Mohamed W; Seraji-Bozorgzad N; Ibrahim M
    J Stroke Cerebrovasc Dis; 2018 Nov; 27(11):2979-2985. PubMed ID: 30093204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of antiplatelet treatment on aneurysmal subarachnoid hemorrhage patients after endovascular treatment: a systematic review with meta-analysis.
    Zhao L; Lin P; Zhang Y; Huang XY; Li HY; Xia MK; Huang X; Li Z; Zhou LX; Tang XP
    Neurosurg Rev; 2022 Dec; 45(6):3523-3536. PubMed ID: 36178562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective Multicenter Study of Changes in MTT after Aneurysmal SAH and Relationship to Delayed Cerebral Ischemia in Patients with Good- and Poor-Grade Admission Status.
    Murphy A; Lee TY; Marotta TR; Spears J; Macdonald RL; Aviv RI; Baker A; Bharatha A
    AJNR Am J Neuroradiol; 2018 Nov; 39(11):2027-2033. PubMed ID: 30337436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of Statins in Cerebral Vasospasm, Mortality, and Delayed Cerebral Ischemia in Patients with Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Shen J; Shen J; Zhu K; Zhou H; Tian H; Yu G
    World Neurosurg; 2019 Nov; 131():e65-e73. PubMed ID: 31295598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CT perfusion for detection of delayed cerebral ischemia in aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis.
    Mir DI; Gupta A; Dunning A; Puchi L; Robinson CL; Epstein HA; Sanelli PC
    AJNR Am J Neuroradiol; 2014 May; 35(5):866-71. PubMed ID: 24309123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Prasugrel and Clopidogrel Used as Antiplatelet Medication for Endovascular Treatment of Unruptured Intracranial Aneurysms: A Meta-Analysis.
    Cagnazzo F; Perrini P; Lefevre PH; Gascou G; Dargazanli C; Riquelme C; Derraz I; di Carlo D; Bonafe A; Costalat V
    AJNR Am J Neuroradiol; 2019 Apr; 40(4):681-686. PubMed ID: 30872419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional Outcomes and Delayed Cerebral Ischemia Following Nonperimesencephalic Angiogram-Negative Subarachnoid Hemorrhage Similar to Aneurysmal Subarachnoid Hemorrhage.
    Al-Mufti F; Merkler AE; Boehme AK; Dancour E; May T; Schmidt JM; Park S; Connolly ES; Lavine SD; Meyers PM; Claassen J; Agarwal S
    Neurosurgery; 2018 Mar; 82(3):359-364. PubMed ID: 28575305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of prior statin use on functional outcome and delayed vasospasm after acute aneurysmal subarachnoid hemorrhage: a matched controlled cohort study.
    Parra A; Kreiter KT; Williams S; Sciacca R; Mack WJ; Naidech AM; Commichau CS; Fitzsimmons BF; Janjua N; Mayer SA; Connolly ES
    Neurosurgery; 2005 Mar; 56(3):476-84; discussion 476-84. PubMed ID: 15730572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study.
    Ehlert A; Schmidt C; Wölfer J; Manthei G; Jacobs AH; Brüning R; Heindel W; Ringelstein EB; Stummer W; Pluta RM; Hesselmann V
    J Neurosurg; 2016 Jan; 124(1):51-8. PubMed ID: 26162034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tirilazad for aneurysmal subarachnoid haemorrhage.
    Zhang S; Wang L; Liu M; Wu B
    Cochrane Database Syst Rev; 2010 Feb; (2):CD006778. PubMed ID: 20166088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspirin and aneurysmal subarachnoid hemorrhage.
    Gross BA; Rosalind Lai PM; Frerichs KU; Du R
    World Neurosurg; 2014 Dec; 82(6):1127-30. PubMed ID: 23548847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.